Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Dec-21 4:25 PM View:  | Elicio Therapeutics, Inc. (ELTX) | 20-Dec-21 | Market Sale (Planned) | 358 | $2.62 | $938.00 | (1%) 35.49K to 35.14K | < 1% |
| 22-Nov-21 7:09 PM View: | Elicio Therapeutics, Inc. (ELTX) | 18-Nov-21 | Market Sale (Planned) | 374 | $4.13 | $1,544.62 | (1%) 35.87K to 35.49K | < 1% |
| 20-Oct-21 5:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 18-Oct-21 | Market Sale (Planned) | 373 | $8.62 | $3,215.26 | (1%) 36.24K to 35.87K | (< 1%) |
| 21-Sep-21 10:00 PM View: | Elicio Therapeutics, Inc. (ELTX) | 20-Sep-21 | Market Sale (Planned) | 376 | $10.07 | $3,786.32 | (1%) 36.62K to 36.24K | (< 1%) |
| 22-Jul-21 6:04 PM View: | Elicio Therapeutics, Inc. (ELTX) | 21-Jul-21 | Market Sale (Planned) | 365 | $10.98 | $4,007.70 | (< 1%) 37.36K to 37.0K | (6%) |
| 21-Jun-21 4:05 PM View: | Elicio Therapeutics, Inc. (ELTX) | 18-Jun-21 | Market Sale (Planned) | 366 | $13.20 | $4,831.20 | (< 1%) 37.73K to 37.36K | (3%) |
| 19-May-21 5:10 PM View: | Elicio Therapeutics, Inc. (ELTX) | 18-May-21 | Market Sale (Planned) | 363 | $13.91 | $5,049.33 | (< 1%) 38.09K to 37.73K | (3%) |
| 20-Apr-21 5:19 PM View: | Elicio Therapeutics, Inc. (ELTX) | 19-Apr-21 | Market Sale (Planned) | 381 | $13.55 | $5,162.55 | (< 1%) 38.47K to 38.09K | (< 1%) |
| 19-Mar-21 4:06 PM View: | Elicio Therapeutics, Inc. (ELTX) | 17-Mar-21 | Market Sale | 442 | $19.13 | $8,455.46 | (1%) 38.9K to 38.45K | 5% |
| 13-Dec-18 4:33 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 148,279 | -- | -- | (100%) 148.28K to 0 | |
| 16-Nov-18 8:49 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Nov-18 | Market Sale | 1,156 | $2.77 | $3,202.12 | (< 1%) 149.44K to 148.28K | (21%) |
| 30-Oct-18 4:07 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Oct-18 | Market Sale | 1,253 | $3.07 | $3,846.71 | (< 1%) 150.69K to 149.44K | (9%) |
| 16-Aug-18 7:10 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Aug-18 | Market Sale | 1,186 | $3.04 | $3,605.44 | (< 1%) 151.87K to 150.69K | (11%) |
| 31-Jul-18 4:34 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jul-18 | Market Sale | 1,282 | $3.86 | $4,948.52 | (< 1%) 153.16K to 151.87K | 13% |
| 16-May-18 4:40 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-May-18 | Market Sale | 1,158 | $5.69 | $6,589.02 | (< 1%) 154.31K to 153.16K | 41% |
| 01-May-18 4:14 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Apr-18 | Market Sale | 1,311 | $4.67 | $6,122.37 | (< 1%) 155.63K to 154.31K | 28% |
| 24-Apr-18 4:29 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 23-Apr-18 | Market Sale | 1,111 | $4.59 | $5,099.49 | (< 1%) 156.74K to 155.63K | 27% |
| 22-Mar-18 5:30 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 41,250 | -- | -- | 36% 115.49K to 156.74K | |
| 16-Feb-18 4:04 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 5,652 | $4.81 | $27,186.10 | (5%) 121.14K to 115.49K | 30% |
| 31-Jan-18 5:19 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Jan-18 | Market Sale | 1,541 | $4.81 | $7,412.21 | (1%) 122.68K to 121.14K | 30% |
| 24-Jan-18 4:16 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 23-Jan-18 | Market Sale | 1,322 | $4.92 | $6,504.24 | (1%) 124.0K to 122.68K | 32% |
| 31-Oct-17 4:12 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Oct-17 | Market Sale | 1,405 | $6.03 | $8,472.15 | (1%) 125.41K to 124.0K | 44% |
| 24-Oct-17 4:21 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 23-Oct-17 | Market Sale | 1,179 | $6.53 | $7,698.87 | (< 1%) 126.58K to 125.41K | 49% |
| 01-Aug-17 4:25 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 31-Jul-17 | Market Sale | 1,445 | $7.14 | $10,317.30 | (1%) 128.03K to 126.58K | 53% |
| 25-Jul-17 5:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 24-Jul-17 | Market Sale | 1,214 | $7.27 | $8,825.78 | (< 1%) 129.24K to 128.03K | 54% |
| 03-May-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 01-May-17 | Market Sale | 1,441 | $5.97 | $8,602.77 | (1%) 130.69K to 129.24K | 44% |
| 26-Apr-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 24-Apr-17 | Market Sale | 1,209 | $5.73 | $6,927.57 | (< 1%) 131.89K to 130.69K | 41% |
| 15-Mar-17 6:31 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 14-Feb-17 | Grant | 48,750 | -- | -- | 59% 83.14K to 131.89K | |
| 31-Jan-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jan-17 | Market Sale | 6,984 | $4.65 | $32,475.60 | (8%) 90.13K to 83.14K | 28% |
| 25-Jan-17 4:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 23-Jan-17 | Market Sale | 1,428 | $5.39 | $7,696.92 | (2%) 91.56K to 90.13K | 38% |
| 25-Oct-16 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 24-Oct-16 | Market Sale | 1,211 | $4.72 | $5,715.92 | (1%) 92.77K to 91.56K | 29% |
| 27-Jul-16 5:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 25-Jul-16 | Market Sale | 1,217 | $7.43 | $9,042.31 | (1%) 93.98K to 92.77K | 55% |
| 27-Apr-16 4:16 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 25-Apr-16 | Market Sale | 4,766 | $5.21 | $24,830.90 | (5%) 98.75K to 93.98K | 36% |
| 01-Feb-16 6:54 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Jan-16 | Grant | 53,750 | -- | -- | 119% 45.0K to 98.75K | |
| 14-Aug-15 7:30 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 12-Aug-15 | Market Purchase | 10,000 | $6.20 | $62,000.00 | 22% 45.0K to 55.0K | (46%) |